A clinical trial of BMND 06
Latest Information Update: 31 Mar 2022
At a glance
- Drugs BMND 06 (Primary)
- Indications Inflammation
- Focus Adverse reactions
Most Recent Events
- 31 Mar 2022 New trial record
- 24 Mar 2022 According to a Biomind Labs media release, company has entered into an agreement with SBiomind Labsociedade Beneficente Israelita Brasileira Hospital Albert Einstein, to conduct this trial.